Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Refludan
Drug ID BADD_D01920
Description Lepirudin is identical to natural hirudin except for substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells. Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.
Indications and Usage For the treatment of heparin-induced thrombocytopenia
Marketing Status Discontinued
ATC Code B01AE02
DrugBank ID DB00001
KEGG ID D06880
MeSH ID C083544
PubChem ID 118856773
TTD Drug ID D09LPN
NDC Product Code Not Available
Synonyms lepirudin | 1-Leu-2-Thr-63-desulfohirudin | HBW 023 | HBW-023 | Refludan | Refludin | Aventis Brand Lepirudin
Chemical Information
Molecular Formula C287H440N80O111S6
CAS Registry Number 138068-37-8
SMILES CCC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C( =O)NC(CSSCC2C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC (=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)C(C)C)CC(=O)N)CO)CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C3 CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(C)C)CC(= O)N)CCC(=O)N)CO)CCC(=O)O)C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC4=CC=C(C= C4)O)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)N)C(=O)N1)CCCCN)CC(=O)N)CCC(=O)N)C(=O)NC(C(C)C )C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)NC( CCCCN)C(=O)N6CCCC6C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NC(CC7=CNC=N7)C(=O)NC(CC(=O)N )C(=O)NC(CC(=O)O)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CC8=CC=CC=C8)C(=O)NC(CCC(=O)O)C( =O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)N9CCCC9C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O )NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)CCC(=O)N)CC(=O)N)CCCC N)CCC(=O)O)CC(=O)O)CO)CC(C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Peritoneal haemorrhage24.07.02.016; 07.07.02.001--Not Available
Pneumonia22.07.01.003; 11.01.09.003--Not Available
Prothrombin level increased13.01.02.011--Not Available
Pruritus23.03.12.001--
Pulmonary embolism24.01.06.001; 22.06.02.001--Not Available
Pulmonary haemorrhage24.07.01.016; 22.02.04.003--
Pyrexia08.05.02.003--
Rash23.03.13.001--Not Available
Rectal haemorrhage07.12.03.001; 24.07.02.018--
Retroperitoneal haemorrhage24.07.01.017; 07.07.02.002--
Seizure17.12.03.001--
Sepsis11.01.11.003--
Shock24.06.02.002--Not Available
Skin disorder23.03.03.007--Not Available
Skin exfoliation23.03.07.003--Not Available
Skin necrosis23.03.03.011--Not Available
Stridor22.04.02.003--
Subcutaneous haematoma23.06.07.003; 24.07.01.033; 12.01.06.005--Not Available
Superinfection11.01.08.009--Not Available
Surgery25.01.02.003--Not Available
Thrombophlebitis24.01.02.001--Not Available
Tongue disorder07.14.01.002--Not Available
Tongue oedema23.04.01.009; 10.01.05.008; 07.14.02.007--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Vaginal haemorrhage24.07.03.005; 21.08.01.001--
Ventricular fibrillation02.03.04.008--
Ventricular tachycardia02.03.04.010--
Vomiting07.01.07.003--
Wound12.01.08.009--Not Available
Haemorrhage24.07.01.002--Not Available
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages